I think this pricing is reasonable, because COVID-19-related drugs, whether vaccines or oral drugs, are injected in emerging markets, and the research and development time of this drug is relatively short, which also determines that research and development need to go hand in hand with multiple routes, and it may cost a lot of money to obtain a usable research route. It needs the efforts of more researchers and more capital investment to get this result, so it is doomed that its research and development cost is very high. If such a high R&D cost is set in 27 yuan, when can it be recovered? Manufacturers of drug R&D have to make money, not to mention the production cost of this new drug itself is not low.
It's a little expensive at first, but I want 270 yuan. If it really works, most people won't use weapons. This is only the initial stage. Later, with the gradual popularization of drugs, the profits of manufacturers were gradually effectively recovered, and the research and development expenses were gradually recovered. Drugs must be negotiated collectively, the medical insurance price will be cheaper, and the cost of real use will be lower. It is not impossible for 270 yuan to become 27 yuan, but it is still impossible in the short term.
COVID-19 has been on and off for nearly three years. For such a long time, I believe that most ordinary people have a basic understanding of this virus, that is, its real mortality rate is not that high. But it is really contagious, and because the virus appears for a short time, a vaccine that can really resist the virus 100% and a drug that can act on it 100% have not been developed. Because of this, it spread violently, but we believe that with the extension of time, this problem can finally be solved.